Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Supplementary figures

Supplementary figures

Files in this Data Supplement:

  • Supplementary figure 1 - Spn infection concurrent and after, but not before (resolved), sensitisation induces CD4+CD25+Foxp3+ Tregs in AAD. (A) Flow cytometry histogram showing the infection concurrent with sensitisation increases Tregs in MLNs. (B) Total numbers, (C) percentages and (D) histograms of CD4+CD25+Foxp3+ Treg cells in MLNs with infection after or before (resolved) sensitisation. # and * represent significant differences compared to uninfected, nonallergic (Saline) and uninfected, allergic (OVA) controls, respectively. #/* p <_0.05.-- end="end" desc="desc" supplementary_figure_1.jpg="supplementary_figure_1.jpg" _--="_--">
  • Supplementary figure 2 - Anti-CD25 treatment reverses the suppressive systemic effects of Spn infection on AAD. OVA-induced cytokine release in splenocyte culture supernatants. # and * represent significant differences compared to uninfected, nonallergic (Saline) and uninfected, allergic (OVA) controls, respectively. #/* p <_0.05 _="_" p0.01="p0.01" and="and" p0.001.--="p0.001.--" end="end" desc="desc" supplementary_figure_2.jpg="supplementary_figure_2.jpg" _--="_--">
  • Supplementary figure 3 - Isotype control antibody does not alter the suppressive effects of Spn infection on AAD. OVA-induced cytokine release in (A) MLN and (B) splenocyte culture supernatants. (C) OVA-specific IgG1 serum antibodies. (D) Eosinophil accumulation in blood, BALF and tissue. (E) Mucus secreting cells surrounding the airway lumen. AHR in terms of averaged peak (F) transpulmonary resistance, and (G) dynamic compliance in response to increasing doses of methacholine; N.B. significant differences in resistance and compliance are for the entire dose response curves. # and * represent significant differences compared to uninfected, nonallergic (Saline) and uninfected, allergic (OVA) controls, respectively. #/* p <_0.05 _="_" p0.01="p0.01" and="and" p0.001="p0.001" n.d.="n.d." no="no" significant="significant" difference.--="difference.--" end="end" desc="desc" supplementary_figure_3.jpg="supplementary_figure_3.jpg" _--="_--">

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society